“FACTORS DETERMINING THE CLINICAL SIGNIFICANCE OF DEPIPTIDYL PEPTIDASE 4 INHIBITORS IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS”. World Bulletin of Public Health 8 (March 13, 2022): 67–72. Accessed April 18, 2026. https://www.scholarexpress.net/index.php/wbph/article/view/651.